Drugs / Hexadecasaccharide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00123565 | Dec 2004 → May 2007 | coronary atherosclerosis | Sanofi | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hexadecasaccharide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00123565 ↗ |
| Known as | SR123781A | “Hexadecasaccharide (SR123781A)” NCT00123565 ↗ |